Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 53, Issue 6, Pages 1023-1031
Publisher
Informa UK Limited
Online
2011-10-24
DOI
10.3109/10428194.2011.631638
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
- (2011) S. E. M. Herman et al. BLOOD
- Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9
- (2011) Andrea G. S. Buggins et al. BRITISH JOURNAL OF HAEMATOLOGY
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2011) P. C. Amrein et al. CLINICAL CANCER RESEARCH
- Endogenous Myc maintains the tumor microenvironment
- (2011) N. M. Sodir et al. GENES & DEVELOPMENT
- Missense Mutations Located in Structural p53 DNA-Binding Motifs Are Associated With Extremely Poor Survival in Chronic Lymphocytic Leukemia
- (2011) Martin Trbusek et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood
- (2011) N Bhattacharya et al. LEUKEMIA
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
- (2010) Thorsten Zenz et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia
- (2010) Y. Herishanu et al. BLOOD
- Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo
- (2010) M. Seiffert et al. BLOOD
- Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
- (2010) P. Dreger et al. BLOOD
- CCL3 (MIP-1 ) plasma levels and the risk for disease progression in chronic lymphocytic leukemia
- (2010) M. Sivina et al. BLOOD
- NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
- (2010) Paolo Sportoletti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain
- (2010) Javier Redondo-Muñoz et al. CANCER CELL
- Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
- (2010) Melissa A. Geller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia
- (2010) T. Zenz et al. HAEMATOLOGICA
- Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2
- (2010) A. Schulz et al. HAEMATOLOGICA
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations
- (2010) T Zenz et al. LEUKEMIA
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting
- (2010) Jan A. Burger SEMINARS IN CANCER BIOLOGY
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
- (2009) M. P. Quiroga et al. BLOOD
- Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression
- (2009) A. K. Ghosh et al. BLOOD
- Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
- (2009) A. V. Kurtova et al. BLOOD
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
- (2009) Jonathan W. Friedberg et al. BRITISH JOURNAL OF HAEMATOLOGY
- A new genetic lesion in B-CLL: aNOTCH1PEST domain mutation
- (2009) Mauro Di Ianni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression
- (2009) Wei Ding et al. BRITISH JOURNAL OF HAEMATOLOGY
- Circulating B-Cell Chronic Lymphocytic Leukemia Cells Display Impaired Migration to Lymph Nodes and Bone Marrow
- (2009) T. N. Hartmann et al. CANCER RESEARCH
- Down-regulation of CXCR4 and CD62L in Chronic Lymphocytic Leukemia Cells Is Triggered by B-Cell Receptor Ligation and Associated with Progressive Disease
- (2009) A. Vlad et al. CANCER RESEARCH
- A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia
- (2009) D E Spaner et al. LEUKEMIA
- The role of Toll-like receptors in chronic B cell malignancies
- (2009) Marta Muzio et al. LEUKEMIA & LYMPHOMA
- Allotransplantation for chronic lymphocytic leukemia
- (2009) P. Dreger Hematology-American Society of Hematology Education Program
- Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection
- (2008) E. M. Ghia et al. BLOOD
- Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
- (2008) C. Pepper et al. BLOOD
- The NF- B subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
- (2008) S. Hewamana et al. BLOOD
- High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
- (2008) J. A. Burger et al. BLOOD
- Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
- (2008) M. Vogler et al. BLOOD
- 4 1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells
- (2008) J. Redondo-Munoz et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients
- (2008) Constantine S. Tam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Expression and function of toll like receptors in chronic lymphocytic leukaemia cells
- (2008) Marta Muzio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Toll-like receptors expressed in tumor cells: targets for therapy
- (2008) Li Yu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Infections and cancer: Established associations and new hypotheses
- (2008) Catherine de Martel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease?
- (2008) Federico Caligaris-Cappio et al. JOURNAL OF CLINICAL ONCOLOGY
- The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia
- (2008) K Giannopoulos et al. LEUKEMIA
- Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2
- (2008) Tatsukata Kawagoe et al. NATURE IMMUNOLOGY
- TLR signaling by tumor and immune cells: a double-edged sword
- (2008) B Huang et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started